DrugPatentWatch Database Preview
Profile for Australia Patent: 2004242967
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Australia Patent: 2004242967
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Aug 25, 2025 | Galderma Labs Lp | MIRVASO | brimonidine tartrate |
Start Trial | May 24, 2025 | Galderma Labs Lp | MIRVASO | brimonidine tartrate |
Start Trial | May 24, 2025 | Galderma Labs Lp | MIRVASO | brimonidine tartrate |
Start Trial | May 24, 2025 | Galderma Labs Lp | MIRVASO | brimonidine tartrate |
Start Trial | Mar 25, 2031 | Galderma Labs Lp | MIRVASO | brimonidine tartrate |
Start Trial | Mar 25, 2031 | Galderma Labs Lp | MIRVASO | brimonidine tartrate |
Start Trial | May 25, 2024 | Galderma Labs Lp | MIRVASO | brimonidine tartrate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |